Image Source: Unsplash

The 7 constituents in the munKNEE American Cannabis MSOs Index are ranked below, in ascending order, as to their stock performances YTD, as follows:

7. Trulieve (TCNNF): DOWN 43.8% YTD 

• 19 Wall Street analysts:
  • have an average 12-month price target representing a 331.3% increase from its current price and
  • have a consensus STRONG BUY rating.

6. Columbia Care (CCHWF): DOWN 36.0% YTD   

• 2 Wall Street analysts:
  • have an average 12-month price target representing a 725.0% increase from its current price and
  • have a consensus STRONG BUY rating.

5. Curaleaf (CURLF): DOWN 27.6% YTD    

• 20 Wall Street analysts:
  • have an average 12-month price target representing a 282.7% increase from its current price and
  • have a consensus STRONG BUY rating.

4. Green Thumb (GTBIF): DOWN 17.0% YTD 

• 21 Wall Street analysts:
  • have an average 12-month price target representing a 174.1% increase from its current price and
  • have a consensus STRONG BUY rating.

3. Cresco Labs (CRLBF): DOWN 14.3% YTD    

• 12 Wall Street analysts:
  • have an average 12-month price target representing a 266.7% increase from its current price and
  • have a consensus BUY rating.

2. Verano (VRNOF): DOWN 9.1% YTD 

• 13 Wall Street analysts:
  • have an average Wall Street analyst 12-month price target representing a 257.1% increase from its current price and
  • have a consensus STRONG BUY rating.

1. TerrAscend (TRSSF): UP 52.7% YTD    

• 11 Wall Street analysts:
  • have an average 12-month price target representing a 42.9% increase from its current price and
  • have a consensus BUY rating.

In total, the sum total of the above 7 constituents in the munKNEE American Cannabis MSOs Index is

• DOWN 22.7% YTD compared to the munKNEE Canadian Cannabis LPs Index which is DOWN 28.0% YTD and
• has an average 12-month Wall Street analyst price target representing a 241.8% increase from today's price as compared to the 5 constituents in the munKNEE Canadian Cannabis LPs Index which have a forward price target representing only a 93.5% increase.

If you are interested in buying a basket of American cannabis multi-sate operator stocks consider the  AdvisorShares Pure U.S. Cannabis ETF (MSOS) that consists of the above 7 highlighted stocks plus an additional 41 smaller cap such stocks. It is DOWN 23.7% YTD.

More By This Author:

The Rise Of the American Debt Ceiling
Cannabis MSOs Remain Volatile: +12% Last Week; -14% So Far This Week
Cannabis LPs Remain Volatile: +10% Last Week; -10% So Far This Week